Bioengineered Wound Care

A comprehensive assessment of the bioengineered wound care technologies and products for advanced wound management, this report provides a detailed analysis of twenty-two next-generation wound care products, including tissue-engineered skin substitutes, synthetic and harvested regeneration matrices, autologous grafts and biologically active cellular therapies. Management of chronic wounds and ulcers remains one of the most costly unsolved healthcare challenges. The report profiles companies active in bioengineered wound care therapeutics, and evaluates technology and business risk factors and market issues. This is a market that is experiencing unabated growth, as the aging of populations in developed countries leads to increasing caseloads of chronic wounds due to disease and immobility. With conditions such as diabetes, a major cause of skin ulcers, forecast to grow worldwide during the next fifteen years, demand for advanced wound care products and therapies will flourish. The report provides an easy-to-understand assessment of bioengineered wound care and the impact it will have on the advanced wound management segment of the healthcare industry.

Publication: August 2009

Summary of Contents (see Prospectus for Full Contents)

Executive Summary

Advanced Wound Care Market Dynamics

Wound Market Segmentation

Acute Wounds

Chronic Wounds & Ulcers

Surgical Wounds

Burns

Market Demographics & Trend Lines

Market Dynamics

Factors Limiting Growth

Wound Care Industry Profile

Industry Structure

Competitive Landscape

Technology Market Drivers

Engineered Wound Care Product Analysis

Acellular Dermal Matrices

Allogeneic Matrices and Sheets

Bilayered Skin Substitutes

Bioabsorbable Scaffolds

Collagen Biomembranes

Collagen Gels

Epidermal Autografts

Oral Tissue Constructs

Xenografts

Market Sector Assessments & Opportunities

Acute Trauma

Burns

Oral Tissue Constructs

Refractory Surgical Wounds

Ulcers

Diabetic Ulcers

Venous Ulcers

Business Sector Strategies and Risks

Proprietary Technology

Near-term Capitalization

Strategic Alliances & Partnerships

Development Stage Transition Factors

Enabling Technologies

Market Factors

Clinical Trial Factors

FDA Guidelines

Reimbursement

Evolving Patient Demographics

Point-of-Care Processing

Protocols and End-Points

Company Profile

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.